Suchergebnisse - (Person:"Jensen, Alexandra")

PubPharm (12)

1

Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease

enthalten in: Emerging infectious diseases | 2020

von Griffin, D. | Jensen, A. | Khan, M. | +6

CommentIn: Emerg Infect Dis. 2020 Oct;26(10):2522-2533. - PMID 32614766

2

Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC

enthalten in: British journal of cancer | 2020

von Rong, C. | Muller, M. | Xiang, F. | +6

3

Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis

enthalten in: British journal of haematology | 2020

von Griffin, D. | Jensen, A. | Khan, M. | +5

4

Radiochemoimmunotherapy with intensity-modulated concomitant boost : interim analysis of the REACH trial

enthalten in: Radiation oncology (London, England) | 2012

von Jensen, A. | Krauss, J. | Potthoff, K. | +5

5

A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer

enthalten in: International journal of radiation oncology, biology, physics | 2012

von Jensen, A. | Nill, S. | Huber, P. | +3

6

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

enthalten in: Radiation oncology (London, England) | 2011

von Jensen, A. | Krauss, J. | Weichert, W. | +4

7

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab : the NEAR trial

enthalten in: Cancer | 2011

von Jensen, A. | Münter, M. | Bischoff, H. | +6

8

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT

enthalten in: BMC cancer | 2011

von Jensen, A. | Krauss, J. | Potthoff, K. | +6

9

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost : ACCEPT [ACC, Erbitux® and particle therapy

enthalten in: BMC cancer | 2011

von Jensen, A. | Nikoghosyan, A. | Hinke, A. | +2

10

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy : the REACH protocol

enthalten in: BMC cancer | 2010

von Habl, G. | Jensen, A. | Potthoff, K. | +7